Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$17,884,702
+$12,982,328 QoQ
Shares Held
14,911
+179.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#944
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $242,744,034 across 9 Drug Manufacturers - General names. LLY ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
452,664 | $58,167,324 | |
| 2 | JNJ |
Johnson & Johnson
|
211,287 | $53,660,559 | |
| 3 | ABBV |
AbbVie Inc.
|
146,723 | $36,921,375 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
558,264 | $32,167,171 | |
| 5 | PFE |
Pfizer Inc
|
1,137,828 | $27,398,898 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
14,911 | $17,884,702 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
67,881 | $8,576,085 | |
| 8 | AMGN |
Amgen Inc
|
20,994 | $7,602,347 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,884,702 | 14,911 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $4,902,374 | 5,330 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $5,982,744 | 5,567 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $4,003,461 | 5,247 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $8,153,104 | 10,459 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $8,676,184 | 10,505 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $7,979,392 | 10,336 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,185,425 | 10,368 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $30,168,166 | 33,321 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $25,922,405 | 33,321 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $19,481,769 | 33,421 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,879,983 | 33,288 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,355,816 | 17,817 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,268,788 | 18,254 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $7,038,761 | 19,240 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,543,310 | 20,236 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,958,950 | 61,558 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $435,322 | 1,576 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $3,872,397 | 16,760 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,050,338 | 17,647 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $3,439,542 | 18,411 | Shares | Other | 2021-05-07 | |
| 2020-12-31 | $3,580,926 | 21,209 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $3,359,756 | 22,698 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $4,016,663 | 24,465 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $2,985,115 | 21,519 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||